Bridgebio Pharma Inc
BBIO
$46.58+0.63 (+1.37%)
Aug 8, 2025, 4:00 PM
Financials
| 52Week High | 49.77 | 52Week Low | 21.72 |
| Beta | 1.35 | Current Ratio Annual | 4.67 |
| Current Ratio Quarterly | 5.19 | Gross Margin TTM | 96.19 |
| Market Cap | 8.90B | Net Profit Margin TTM | -329.25 |
| Operating Margin TTM | -265.28 | Price To Book | 153.79 |
| Price To Sales TTM | 37.76 | Quick Ratio Annual | 4.44 |
| Quick Ratio Quarterly | 4.74 | Return On Assets TTM | -87.58 |
| Return On Equity TTM | -206.74 | Return On Investment TTM | -65.34 |
| Revenue Growth3Y | 47.10 | Revenue Growth5Y | 40.48 |
| Revenue Growth Quarterly Yoy | 4,999.86 | Revenue Growth TTMYoy | 7.62 |
| Revenue Per Share TTM | 1.24 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 308 | 69 | 33 | 117 | 84 | 29 | 200.03M | $6.81B |
| Jun 30, 2025 | 115 | 30 | 9 | 47 | 26 | 7 | 10.54M | $446.70M |
| Change | 193(63%) | 39(57%) | 24(73%) | 70(60%) | 58(69%) | 22(76%) | 189.49M(95%) | $6.36B(93%) |